TradingView · 22 Oct, 09:46 · Healthcare briefing

Jamjoom Pharma And Mubadala Bio’s Venture Healthcare Partner To Expand Patient Access To Ustekinumab In UAE

Jamjoom Pharma has entered a strategic partnership with Mubadala Bio’s Venture Healthcare to broaden patient access to ustekinumab within the United Arab Emirates.

What it means for you ↓ Courses for this story

31%salary uplift reported after healthcare management certification

13%projected growth in health services roles this decade

2.1xmore interview callbacks with a verified credential

20days to your first credential

The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

Jamjoom Pharma has entered a strategic partnership with Mubadala Bio’s Venture Healthcare to broaden patient access to ustekinumab within the United Arab Emirates. This collaboration aims to enhance the availability of this specific biologic treatment for local patients. The agreement underscores a growing trend of joint ventures between established pharmaceutical distributors and specialised healthcare investors in the region. Such moves typically streamline supply chains and improve market penetration for high-cost therapies. For industry observers, this signals continued consolidation and strategic alignment in the Middle Eastern healthcare sector, focusing on improving accessibility for critical medications through combined operational expertise and financial backing.

Employer demand for Healthcare Management skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)

Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

This partnership signals a shift toward integrated care models in the UAE, making roles in commercial strategy and regulatory affairs increasingly vital. You should focus on understanding cross-border healthcare regulations and market access strategies. Professionals in pharmaceutical sales must adapt to more complex stakeholder landscapes involving both private and semi-government entities. Upskill in healthcare analytics to track patient outcomes and treatment efficacy, as data-driven decisions will drive future partnerships. If you work in operations, study supply chain resilience for cold-chain biologics. Smart professionals will network with counterparts in venture-backed healthcare firms, recognising that funding models are evolving. Prioritise learning about value-based care frameworks, as payers demand evidence of cost-effectiveness. This is not merely a distribution deal; it is a test case for scalable access models that you can leverage in your own career trajectory within the region’s booming healthtech and pharma sectors.

For this story, the fields that convert it into pay are Healthcare Management, AI in Pharmaceuticals, Supply Chain and Compliance And Governance — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below

Matched to this story

Enrol in these
to benefit.

These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.